Member Exclusive

Novel prodrug used to precisely target lung cancer

A new anti-EGFR drug has been developed by researchers at the University of Colorado Anschutz Medical Campus that will precisely target tumors thanks to its attached ‘tail’.

Go to the profile of MedChemNet
Nov 02, 2017

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.